Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hepatobiliary and Pancreatic Diseases International is Scopus-indexed (Q1, CiteScore 7.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier (Singapore) Pte Ltd.
Checked against the index lists dated .
ISSN 1499-3872Verify ISSN ↗2352-9377Verify ISSN ↗
Publisher: Elsevier (Singapore) Pte Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Gastroenterology | 25 / 176 | 86th | Q1 |
| Hepatology | 20 / 88 | 77th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q1, CiteScore 7.2.
Hepatobiliary and Pancreatic Diseases International is Q1 in Gastroenterology (rank 25 of 176) and Q1 in Hepatology (rank 20 of 88), by CiteScore 2025.
Hepatobiliary and Pancreatic Diseases International is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.2, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.021, quartile Q1, with an H-index of 61.
Hepatobiliary and Pancreatic Diseases International is published by Elsevier (Singapore) Pte Ltd. Its print ISSN is 1499-3872 and its online ISSN is 2352-9377.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Hepatobiliary and Pancreatic Diseases International has an h-index of 56 and a 2-year mean of 1.43 citations per paper (OpenAlex). Its Scopus CiteScore is 7.2, quartile Q1. On 2-year citations it ranks #87 of 172 Scopus journals in Gastroenterology.
Hepatobiliary and Pancreatic Diseases International published 96 papers in 2025; its busiest recent year was 2022 with 141. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from China (71.4%), Italy (3.5%) and India (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.